Search results
Jazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript
Insider Monkey via Yahoo Finance· 3 days agoJazz Pharmaceuticals plc (NASDAQ:JAZZ) Q1 2024 Earnings Call Transcript May 1, 2024 Jazz...
Jazz Pharma to Fight FDA in Court Over Rival Sleep Drug Approval
Bloomberg Law· 1 day ago...district court that the FDA violated an orphan drug law when it approved a rival product. will take to the US District Court for the District of Columbia to argue its case against the Food and Drug Administration on whether the agency violated the Orphan Drug Act when it approved Avadel CNS...
Japan's Takeda Pharma to restructure after annual profit slump
Reuters via Yahoo News· 1 day agoTOKYO (Reuters) -Japan's Takeda Pharmaceutical announced a restructuring on Thursday after annual...
Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcrip
Guru Focus· 4 days agoFor the complete transcript of the earnings call, please refer to the full earnings call transcript. Axsome Therapeutics Inc (AXSM, Financial) reported a strong financial performance with total ...
Earnings call: Axsome Therapeutics sees robust growth in Q1 2024 By Investing.com
Investing.com· 4 days agoAxsome Therapeutics (NASDAQ: NASDAQ:AXSM) reported a significant year-over-year revenue increase of...
Woman warned to seek medical help after dog starts acting oddly around her
Daily Mirror· 5 days agoA woman has been left worried by her dog's strange mannerisms and, after asking advice online, she's...
Japan's Takeda Pharma to restructure after annual profit slump
Reuters· 1 day ago, opens new tab announced a restructuring on Thursday after annual profit slid by more than half...
The Bruins’ survival, the Maple Leafs’ heartbreak, and other final thoughts from an absurd...
The Boston Globe· 5 days agoTied at 1-1 entering OT Saturday night, the Leafs chose an inopportune time for their five skaters...
Axsome Therapeutics Inc (AXSM) (Q1 2024) Earnings Call Transcript Highlights: Soaring Revenues ...
GuruFocus.com via Yahoo Finance· 3 days agoThe company announced positive top-line results for AXS-12 in narcolepsy, which achieved its primary endpoint and significantly reduced the frequency of cataplexy attacks ...
Q1 2024 Axsome Therapeutics Inc Earnings Call
Thomson Reuters StreetEvents via Yahoo Finance· 4 days agoFirst quarter of 2024 was marked by strong financial performance for our own market products, which are delivering important and differentiated treatment options for patients living with depression ...
